Clinical Trials Browser

NIH × Hypophosphatemia × infigratinib × Clear all

NCT03510455 2021-04-08

BGJ398 for the Treatment of Tumor-Induced Osteomalacia

Phase 2 Terminated

4 enrolled 28 charts

Oncogenic osteomalacia, Hypophosphatemia